VC-Backed Gossamer Bio Begins Trading After $276M IPO
Law360 (February 8, 2019, 4:36 PM EST) -- San Diego-based biopharmaceutical company Gossamer Bio started trading on the Nasdaq Global Select Market on Friday after the Latham & Watkins LLP-led company priced a $276 million initial public offering....
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
